Abstract. In disease-endemic areas, histoplasmosis is the main differential diagnosis for tuberculosis among human immunodeficiency virus (HIV)-infected patients. However, no study has compared the two diseases. Thus, the objec- . Tuberculosis and histoplasmosis have similarities, but some factors show a greater association with one of these diseases. Thus, adapted therapeutic choices can be made by using simple clinical and paraclinical criteria.
INTRODUCTION
With an acquired immunodeficiency syndrome (AIDS) incidence 10 times higher than the incidence in mainland France, and a prevalence 1%, French Guiana is the French territory where the human immunodeficiency virus (HIV) epidemic is the most preoccupying. 1 Histoplasmosis and tuberculosis are among the top four AIDS-defining illnesses. Disseminated histoplasmosis was the first AIDS-related cause of death in 2005. 2, 3 Histoplasmosis and tuberculosis during the HIV infection are often seen as disseminated infections. With the aggravation of immunodeficiency, dissemination of the pathogen causes a rapid and fatal evolution in the absence of treatment. 4, 5 At this stage, invasive diagnostic methods are necessary. Biological confirmation through pathogen identification by culture is long and sometimes difficult in cases of profound immunosuppression. Rapid and sensitive antigenic detection techniques are not available in most countries. 6 The non-specific nature of the clinical, biologic, histologic, and radiologic findings for these two diseases makes differential diagnosis of histoplasmosis difficult in disease-endemic areas. Thus, numerous publications report cases of histoplasmosis mimicking tuberculosis, most often because of the absence of diagnostic facilities or because a diagnosis of histoplasmosis was not considered. [7] [8] [9] [10] [11] Although studies before the HIV era reported a high prevalence of positive histoplasmin test results there have been few publications on this disease in the Caribbean and the Guianas. 3, 12, 13 In low-resource countries, a number of AIDS cases may die of histoplasmosis mistaken for multidrugresistant tuberculosis. 10, 14, 15 In French Guiana, because of their high incidence, clinicians generally suspect histoplasmosis and tuberculosis in immunosuppressed patients at admission. Prolonged hospitalizations are often necessary for identification of infecting pathogens by invasive procedures. Mycologic and mycobacteriologic screening are systematically performed. Frequently, a presumptive treatment is initiated before culture results are obtained. 16 In this context, a comparative study between tuberculosis and histoplasmosis seems straightforward and might be useful. A systematic review of the literature showed that since 1906, studies on the differential diagnosis of tuberculosis and histoplasmosis have not been conducted. 17 Although it is assumed that these two diseases are similar, there is little basis for making this conclusion.
The objective of this study was to compare tuberculosis and histoplasmosis in HIV-infected patients to identify epidemiologic, clinical, biologic, and radiologic differences. A secondary objective was to help therapeutic decisions in life-threatening situations. To identify criteria independently associated with tuberculosis and histoplasmosis, stepwise unconditional logistic regression was used. 20 Forward and backward models were used to verify convergence. The dependent variable was tuberculosis or histoplasmosis, coded 0 and 1 respectively. Odds ratios (ORs) and 95% confidence intervals were obtained. For an OR 1, the variable was associated with tuberculosis, and for an OR 1, the variable was associated with histoplasmosis.
MATERIALS AND METHODS
To select variables for the multivariate model, bivariate logistic regression models used categorical independent variables. In the absence of similar studies in the literature, the cut-off value was the median or mean according to the distribution of continuous variables. For some variables, the reference laboratory threshold was used because it was clinically meaningful (i.e., for platelet counts, the median was 222,000/mm 3 , but categorization used a threshold 150,000/mm 3 ). For ferritinemia, some ferritin concentrations were 1,000 μg/L. To avoid confusion, the variable was categorized as or 1,000 μg/L.
Age, sex, and variables that had a P 0.2 were used in the multivariate model. Variables with a P 0.2 (systolic and diastolic blood pressure, chest computed tomography scan, abdominal ultrasonography, albuminemia, serum iron level, ferritinemia, triglyceridemia, and fibrinogenemia) were not included in this model because of a large number of missing values and to avoid a large proportion of persons who were dropped from the final model. The saturated multivariate model included 156 patients.
RESULTS
Results of univariate and bivariate analysis are shown in Table 1 . The study population consisted of 205 HIV-positive persons. Two groups were defined: 99 persons with tuberculosis and 106 persons with histoplasmosis. There was a predominance of males in both groups. The mean ± SD age was similar in both groups (39.3 ± 11.6 for persons with tuberculosis and 41.6 ± 10.6 for persons with histoplasmosis) (P = 0.151).
The proportion of patients from Guyana and Brazil was greater for those with tuberculosis than for those with histoplasmosis. The proportion of patients originating from French Guiana and Suriname was significantly greater for those with histoplasmosis than for those with tuberculosis. Similarly, the proportion of patients having spent 18 years in French Guiana was greater for persons with histoplasmosis than for those with tuberculosis. The proportion of patients residing outside the Cayenne urban community (residing mostly in western French Guiana along the Maroni River) was significantly greater for person with histoplasmosis than for those with tuberculosis. More specifically, patients residing along the Maroni River represented 17% of persons with histoplasmosis and 7% of those with tuberculosis (P = 0.047).
Tuberculosis and histoplasmosis were AIDS-defining events for most persons. The proportion of persons receiving antiretroviral treatment and/or taking trimethoprimsulfamethoxazole primary prophylaxis on admission was low in both groups. A history of opportunistic infections was in similar proportions in both groups. A major proportion of patients were febrile on admission in both groups. Dyspnea, abdominal pain, diarrhea, and neurologic signs were frequent in both groups, but there was no significant difference.
The presence of concomitant opportunistic infections was more frequent in persons with histoplasmosis than in those with tuberculosis. Tobacco addiction was more frequent in persons with tuberculosis than in those with histoplasmosis. Similarly, multiple addictions were significantly more frequent in persons with tuberculosis than in those with histoplasmosis.
The proportion of patients with a Eastern Cooperative Oncology Group/World Health Organization performance status score 2 was significantly greater for persons with histoplasmosis than for those with tuberculosis. Although most patients were febrile at admission, the mean ± SD temperature was significantly higher for person with histoplasmosis (39.5 ± 0.9 C) than for persons with tuberculosis (39.0 ± 1.0 C) (P = 0.021). The median (interquartile range [IQR]) evolution duration of fever was 30 (8-60) days for persons with tuberculosis and 21 (10-30) days for persons with histoplasmosis (P = 0.390). The proportion of persons with a systolic blood pressure 90 mm Hg and a diastolic blood pressure 60 mm Hg was significantly higher in persons with histoplasmosis than in those with tuberculosis.
Initial physical examination showed that symptoms involving the pleuro-pulmonary sphere were more frequent in those with tuberculosis (78%) than in those with histoplasmosis (49%) (P 0.001) (Figure 1) . The proportion of patients with cough and/or chest pain was higher in persons with tuberculosis than in those with histoplasmosis. Symptoms involving the abdominal sphere were more frequent in persons with histoplasmosis (70%) than in those with tuberculosis (48%) (P = 0.001) (Figure 1 ). Hepatomegaly and/or splenomegaly was significantly more frequent in persons with histoplasmosis than in those with tuberculosis. Lymphadenopathy 2 cm was greater in persons with histoplasmosis (29%) than in those with tuberculosis (15%) (Figure 1) .
Chest radiographs showed an interstitial syndrome that was comparable in both groups. The proportion of patients with deep lymphadenopathy and/or ascitis was also similar in both groups. Chest radiographs also showed that an alveolar syndrome and/or pleural effusions and/or pulmonary infiltrates were greater in persons with tuberculosis than in those with histoplasmosis. Abdominal ultrasonography showed that hepatomegaly and/or splenomegaly were greater in persons with histoplasmosis than in those with tuberculosis.
Blood counts showed that the median CD4 cell count was low in both groups (111 cells/mm 3 , IQR = 48-259 for persons with tuberculosis and 37/mm 3 , IQR = 15-84 for persons with histoplasmosis). The average hemoglobin level was decreased in both groups. There was no significant difference in prothrombin rate for both groups.
Immunosuppression was more advanced for persons with histoplasmosis than for those with tuberculosis. Anemia (hemoglobin level 9 g/dL) was significantly more pronounced for persons with histoplasmosis than for those with tuberculosis. Neutrophil count was significantly lower in persons with histoplasmosis than in those with tuberculosis. Thrombocytopenia (platelet count 150,000/mm) was more frequent in persons with histoplasmosis than in those with tuberculosis ( Figure 1) . The proportion of patients with fibrinogenemia 4.2 g/L (laboratory threshold) was significantly higher for persons with tuberculosis than for those with histoplasmosis.
Median levels of lactate dehydrogenase (LDH) were increased in both groups (328 IU/L, IQR = 231-491 for persons with tuberculosis and 446 IU/L, IQR = 316-1,216 for those with histoplasmosis). Renal failure or hypoalbuminemia was observed in both groups.
Abnormal liver test results were more frequent in persons with histoplasmosis than in those with tuberculosis ( Figure 1 ). Hepatic cytolysis (aspartate aminotransferase levels 34 IU/L and alanine aminotransferase levels 44 IU/L) and cholestasis (γ-glutamyl transferase levels 72 IU/L and alkaline phosphatase levels 100 IU/L) were significantly more frequent in persons with histoplasmosis. Lactate dehydrogenase levels 365 IU/L were more frequent in persons with histoplasmosis (57%) than in those with tuberculosis (40%). C-reactive protein levels 70 mg/L were more frequent in *OR = odds ratio; CI = confidence interval; AIDS = acquired immunodeficiency syndrome; WHO = World Health Organization; CT = computed tomography; AST = aspartate aminotransferase; ALT = alanine aminotransferase. Bivariate analysis was conducted by using a logistic regression model. †Variables selected for the multivariate analysis model. ‡Dummy variables were created for the geographic origin and the residence location with Haiti and the Cayenne urban community as the respective referent population coded as 1. §Threshold of 18 years corresponds to the median.
persons with tuberculosis than in those with histoplasmosis ( Figure 1 ). Ferritinemia 1,000 μg/L and/or triglyceridemia 1.72 mmol/L (laboratory threshold) were significantly more frequent in persons with histoplasmosis than in those with tuberculosis. Lymph node localizations of microorganisms were similar in both groups (18% for persons with tuberculosis and 20% for those with histoplasmosis). Isolates from pleural and pulmonary localizations were more frequent in persons with tuberculosis than in those with histoplasmosis. Isolates from localizations, such as bone marrow, liver, gastrointestinal tract and peripheric blood, were significantly more frequent in persons with histoplasmosis than in those with tuberculosis.
A subgroup of patients who did not have concomitant opportunistic infections was analyzed separately to verify that the results were not affected by concurrent opportunistic infections. There were 91 cases of tuberculosis and 80 cases of histoplasmosis. Replication of the above analyses in this subgroup showed identical differences, suggesting that concomitant infections did not confound the above results.
Multivariate analysis. Forward and backward stepwise logistic regression converged on identical models. Results from multivariate analysis are shown in Table 2 and significant results according to the forward model are shown in Figure 2 .
Variables significantly associated with tuberculosis were cough and a C-reactive protein level 70 mg/L. Variables significantly associated with histoplasmosis were γ-glutamyl transferase level 72 IU/L, origin from French Guiana, disseminated localizations, concomitant opportunistic infections, neutrophil count 2,750 cells/mm 3 , CD4 cell count 60 cells/mm 3 , and platelet count 150,000/mm 3 .
DISCUSSION
Tuberculosis and histoplasmosis have similar symptoms. 8, 21, 22 This study tested whether histoplasmosis and tuberculosis are indiscernible in HIV-infected patients. Although these pathologies share certain similarities, there are clinical and laboratory differences. Tuberculosis was more frequent among patients from Guyana and Brazil, and histoplasmosis was more frequent among patients from French Guiana and Suriname. Residence duration in French Guiana and residence location outside urban was more frequent in persons with histoplasmosis. Thus, tuberculosis seemed to be an urban pathology and histoplasmosis seemed more to be a rural pathology, notably near the Maroni River.
Most patients did not take any treatment (antiretroviral or primary prophylaxis) at the time of diagnosis. It was therefore not surprising to observe concurrent opportunistic infections, notably in patients with histoplasmosis.
The initial clinical presentation in both groups was dominated by prolonged fever in a context of poor general condition, notably weight loss. However, this condition was more pronounced in persons with histoplasmosis.
Symptoms involving the pleuro-pulmonary sphere were more frequent in persons with tuberculosis, and M. tuberculosis was more frequently identified at the pleuro-pulmonary level (Figure 1) . Similarly, cough or chest pain associated with abnormal chest radiograph results were more frequent in persons with tuberculosis. Although an interstitial syndrome was observed in both groups, alveolar syndrome and pulmonary infiltrate were more evocative of tuberculosis.
Conversely, symptoms or abnormal medical imagery results involving the abdominal sphere were more frequent in persons with histoplasmosis. Histoplasma capsulatum was identified more frequently at the abdominal level (liver and gastrointestinal tract). Hepatomegaly, splenomegaly, and lower digestive bleeding associated with abnormal abdominal ultrasonographic results were more frequent in persons with histoplasmosis. Although the presence of deep lymphadenopathy was similar in both groups, hepatomegaly or splenomegaly were more frequent in persons with histoplasmosis. Lymph node localizations were frequently observed in both groups, but lymphadenopathy 2 cm seemed more evocative of histoplasmosis. Most cases of histoplasmosis were disseminated forms, presumably because of greater immunodepression than in tuberculosis cases, facilitating dissemination of the pathogen.
Results of standard biologic tests showed numerous differences. Although anemia was common in both groups, it was more frequent in persons with histoplasmosis. It was generally part of pancytopenia, which was also significantly more frequent in persons with histoplasmosis. Moreover, abnormal liver test results (hepatic cytolysis and cholestasis), increased LDH levels, and hypertriglyceridemia were more frequent in persons with histoplasmosis than in those with tuberculosis. Conversely and independent of CD4 cell counts, inflammatory markers were more frequent in persons with tuberculosis than in those with histoplasmosis (increased levels of C-reactive protein and fibrinogen), but ferritinemia (ferritin concentration 1,000 μg/L) was more frequent in persons with histoplasmosis.
Increased LDH levels have been reported as an indicator for diagnosis of tuberculosis and histoplasmosis 16, 23, 24 and as a prognostic factor in severe disseminated forms of histoplasmosis. 6 In the present study, after adjusting for CD4 cell counts, we found no significant difference in LDH levels between persons with tuberculosis and those Ferritin concentration has also been described as an indicator for the diagnosis of severe disseminated histoplasmosis. 25 However, because of a large number of missing values, this variable was not selected for multivariate analysis.
This study had limitations. Data were collected retrospectively, which might have led to selection biases. Missing values for certain variables that were not included in the regression model may not have been missing randomly and were most likely influenced by clinical experience of the physicians. Histoplasmosis and tuberculosis represent only 50% of AIDS-defining illnesses in French Guiana, a finding that does not enable definition of decisional algorithms adapted to clinical situations.
Despite its limitations, this study is the first to compare tuberculosis and histoplasmosis among HIV-positive patients. A study reported excessive mortality in patients receiving antituberculosis treatment because of lack of knowledge about histoplasmosis or diagnostic difficulties. 10 Thus, not knowing the differences between tuberculosis and histoplasmosis is a serious concern because it should strongly encourage clinicians in disease-endemic areas to conduct invasive diagnostic procedures or initiate presumptive treatment, notably in the presence of severity criteria. 16, 26 Nevertheless, in addition to a high clinical suspicion index, there is a need for an affordable, specific, sensitive, user friendly, robust, rapid, equipment free, and deliverable diagnostic tool to help clinicians in low-resource countries diagnose histoplasmosis.
The question initiating this study was whether tuberculosis and histoplasmosis in HIV-infected patients are clinically similar. The answer to this question is no. Although tuberculosis and histoplasmosis have similarities, a certain number of particularities described in this report can aid therapeutic decisions by clinicians, notably when a short-term prognosis is at risk.
